共 50 条
Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment
被引:28
|作者:
Abenavoli, Ludovico
[1
]
Masarone, Mario
[2
]
Federico, Alessandro
[3
]
Rosato, Valerio
[4
]
Dallio, Marcello
[3
]
Loguercio, Carmela
[3
]
Persico, Marcello
[2
]
机构:
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Campus Germaneto, I-88100 Catanzaro, Italy
[2] Univ Salerno, Internal Med & Hepatol Unit, I-84100 Salerno, Italy
[3] Univ Naples 2, Gastroenterol & Endoscopy Unit, I-80131 Naples, Italy
[4] Univ Naples 2, Internal Med & Hepatol Dept, I-80131 Naples, Italy
关键词:
Abstinence;
acetaldehyde;
alcohol;
alcoholic hepatitis;
alcoholic liver disease;
cirrhosis;
fibrosis;
endoscopy;
gastropathy;
D O I:
10.2174/1574887111666160724183409
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Alcohol represents the oldest substance of abuse known and Alcoholic Liver Disease (ALD) is the most common cause of chronic liver disease worldwide. The ALD includes a wide spectrum of injury and may lead progressively from simple steatosis to frank cirrhosis. The ALD diagnosis may be hard and it is mainly defined by the history of chronic alcohol intake, physical and laboratory abnormalities suggestive of liver disease. Abstinence is the cornerstone of ALD therapy. Although the burden on health of ALD is not negligible, in the last decades few therapeutic advances have been made. Because of the complex pathogenetic mechanisms, the therapy of ALD and especially of severe Alcoholic Hepatitis (AH), represents a thorny problem in the clinical practice. In severe forms of acute AH, some specific drug treatments, including glucorticoids or pentoxifylline, have been defined and are, at the moment, recommended by international guidelines. On the contrary, specific long-term treatments of ALD, aimed at stopping the progression of fibrosis, are not yet approved.
引用
收藏
页码:159 / 166
页数:8
相关论文